Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1532-429X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pioglitazone alters fat distribution in patients with type 2 diabetes mellitus, in contrast to metformin ; volume:11 ; number:1 ; day:28 ; month:1 ; year:2009 ; pages:1-316 ; date:1.2009
Journal of cardiovascular magnetic resonance ; 11, Heft 1 (28.1.2009), 1-316, 1.2009
- Urheber
-
Jonker, Jacqueline T.
- Beteiligte Personen und Organisationen
-
van der Meer, Rutger W.
Rijzewijk, Luuk J.
Menting, Lisa M.
Diamant, Michaela
Romijn, Johannes A.
Smit, Johannes WA
de Roos, Albert
Lamb, Hildo J.
SpringerLink (Online service)
- DOI
-
10.1186/1532-429X-11-S1-P113
- URN
-
urn:nbn:de:1111-2016032160216
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Jonker, Jacqueline T.
- van der Meer, Rutger W.
- Rijzewijk, Luuk J.
- Menting, Lisa M.
- Diamant, Michaela
- Romijn, Johannes A.
- Smit, Johannes WA
- de Roos, Albert
- Lamb, Hildo J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
Correction: A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial
The effects of metformin in type 1 diabetes mellitus
Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation
Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial
Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study
Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis
A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
Correction: A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial
The effects of metformin in type 1 diabetes mellitus
Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation
Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial
Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study
Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin
Pioglitazone and breast cancer risk in female patients with type 2 diabetes mellitus: a retrospective cohort analysis
A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
Correction: A meta-analysis of randomized clinical trials on the effect of metformin vs. pioglitazone monotherapy on plasma adiponectin levels among patients with diabetes mellitus
Efficacy and Safety of Pioglitazone/Metformin Fixed-Dose Combination Versus Uptitrated Metformin in Patients with Type 2 Diabetes without Adequate Glycemic Control: A Randomized Clinical Trial
The effects of metformin in type 1 diabetes mellitus
Beneficial effects of pioglitazone and metformin in murine model of polycystic ovaries via improvement of chemerin gene up-regulation
Randomized placebo control study of insulin sensitizers (Metformin and Pioglitazone) in psoriasis patients with metabolic syndrome (Topical Treatment Cohort)
Metformin versus metformin plus pioglitazone on gonadal and metabolic profiles in normal-weight women with polycystic ovary syndrome: a single-center, open-labeled prospective randomized controlled trial
Comparative Efficacy of Lobeglitazone Versus Pioglitazone on Albuminuria in Patients with Type 2 Diabetes Mellitus
Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: a nested case–control study
Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin